• Je něco špatně v tomto záznamu ?

Osteosarcomas of the hand and foot: A sarcoma‐center case series experience

M. Mahdal, V. Apostolopoulos, L. Pazourek, I. Staniczková Zambo, D. Adámková, P. Múdry, D. Zoufalý, T. Tomáš

. 2025 ; 29 (1) : 54. [pub] 20241112

Status neindexováno Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25001887

Hand and foot osteosarcoma represents ~1% of all diagnosed cases of osteosarcoma. The rarity of osteosarcoma of the hand and foot leads to frequent misdiagnosis, delayed diagnosis or incorrect treatments, which can lead to fatal consequences. Typically, salvaging the affected limb is the treatment of choice, and with the use of chemotherapy, 60-65% of patients with osteosarcoma can be treated without amputation. Due to its rarity, misdiagnosis and treatment delays are common, yet detailed reviews and analyses of such cases are limited. The present retrospective cohort study aimed to review and analyze cases of osteosarcoma located in the hand and foot. From January 2007 to January 2019, 11 patients were treated at the Masaryk Memorial Cancer Institute Sarcoma Center (Brno, Czechia), 5 cases affected the hand and 6 affected the foot. A total of 6 male patients and 5 female patients, with a mean age of 30.9±16.74 years, were diagnosed with hand or foot osteosarcoma. The mean follow-up period was 90.36±66.14 months. The mean tumor size detected during diagnosis was 4.29±1.81 cm. Osteoblastic osteosarcoma was the most common histopathological type, accounting for 4 cases (33.4%). A majority of the osteosarcomas were identified as high grade (81.8%). A total of 5 patients experienced misdiagnoses following their initial biopsy, with 2 patients initially receiving treatment outside the Masaryk Memorial Cancer Institute Sarcoma Center. The most frequently encountered misdiagnosis was giant-cell tumor of the bone. A total of 3 patients underwent limb amputation and 2 patients developed lung metastasis and succumbed to the disease. The disease-free survival period and overall survival rate were calculated using Kaplan-Meier survival analysis. The mean disease-free survival period was 82.83±60.05 months, while the overall survival rate was 72%, with a mean survival time of 90.36±56.73 months. In summary, an examination of a case series involving 11 patients diagnosed with osteosarcoma of the hand and foot was conducted. The treatment approach, clinical characteristics and patient outcomes were described. A total of four case studies of patients with osteosarcoma in the hand or foot were presented. Misdiagnosis of this disease may result in the inappropriate treatment being administered to patients, therefore, the correct and rapid diagnosis of disease is necessary for effective treatment of hand and foot osteosarcomas.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25001887
003      
CZ-PrNML
005      
20250123101951.0
007      
ta
008      
250117s2025 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ol.2024.14800 $2 doi
035    __
$a (PubMed)39574804
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Mahdal, Michal $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200 Brno, Czechia $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia
245    10
$a Osteosarcomas of the hand and foot: A sarcoma‐center case series experience / $c M. Mahdal, V. Apostolopoulos, L. Pazourek, I. Staniczková Zambo, D. Adámková, P. Múdry, D. Zoufalý, T. Tomáš
520    9_
$a Hand and foot osteosarcoma represents ~1% of all diagnosed cases of osteosarcoma. The rarity of osteosarcoma of the hand and foot leads to frequent misdiagnosis, delayed diagnosis or incorrect treatments, which can lead to fatal consequences. Typically, salvaging the affected limb is the treatment of choice, and with the use of chemotherapy, 60-65% of patients with osteosarcoma can be treated without amputation. Due to its rarity, misdiagnosis and treatment delays are common, yet detailed reviews and analyses of such cases are limited. The present retrospective cohort study aimed to review and analyze cases of osteosarcoma located in the hand and foot. From January 2007 to January 2019, 11 patients were treated at the Masaryk Memorial Cancer Institute Sarcoma Center (Brno, Czechia), 5 cases affected the hand and 6 affected the foot. A total of 6 male patients and 5 female patients, with a mean age of 30.9±16.74 years, were diagnosed with hand or foot osteosarcoma. The mean follow-up period was 90.36±66.14 months. The mean tumor size detected during diagnosis was 4.29±1.81 cm. Osteoblastic osteosarcoma was the most common histopathological type, accounting for 4 cases (33.4%). A majority of the osteosarcomas were identified as high grade (81.8%). A total of 5 patients experienced misdiagnoses following their initial biopsy, with 2 patients initially receiving treatment outside the Masaryk Memorial Cancer Institute Sarcoma Center. The most frequently encountered misdiagnosis was giant-cell tumor of the bone. A total of 3 patients underwent limb amputation and 2 patients developed lung metastasis and succumbed to the disease. The disease-free survival period and overall survival rate were calculated using Kaplan-Meier survival analysis. The mean disease-free survival period was 82.83±60.05 months, while the overall survival rate was 72%, with a mean survival time of 90.36±56.73 months. In summary, an examination of a case series involving 11 patients diagnosed with osteosarcoma of the hand and foot was conducted. The treatment approach, clinical characteristics and patient outcomes were described. A total of four case studies of patients with osteosarcoma in the hand or foot were presented. Misdiagnosis of this disease may result in the inappropriate treatment being administered to patients, therefore, the correct and rapid diagnosis of disease is necessary for effective treatment of hand and foot osteosarcomas.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Apostolopoulos, Vasileios $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200 Brno, Czechia $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia
700    1_
$a Pazourek, Lukáš $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200 Brno, Czechia $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia
700    1_
$a Staniczková Zambo, Iva $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia $u First Pathology Department, St. Anne's University Hospital, 60200 Brno, Czechia
700    1_
$a Adámková, Dagmar $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia $u Clinic of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 60200 Brno, Czechia
700    1_
$a Múdry, Peter $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia $u Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czechia
700    1_
$a Zoufalý, Dušan $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia $u First Pathology Department, St. Anne's University Hospital, 60200 Brno, Czechia
700    1_
$a Tomáš, Tomáš $u First Department of Orthopaedic Surgery, St. Anne's University Hospital, 60200 Brno, Czechia $u Faculty of Medicine, Masaryk University, 62500 Brno, Czechia
773    0_
$w MED00193499 $t Oncology letters $x 1792-1082 $g Roč. 29, č. 1 (2025), s. 54
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39574804 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101945 $b ABA008
999    __
$a ok $b bmc $g 2254418 $s 1237890
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 29 $c 1 $d 54 $e 20241112 $i 1792-1082 $m Oncology letters $n Oncol Lett $x MED00193499
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace